Ulinastatin
- Generic Name
- Ulinastatin
- Drug Type
- Biotech
- CAS Number
- 80449-31-6
- Unique Ingredient Identifier
- OR3S9IF86U
- Background
Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
Ulinastatin's Anti-inflammatory Reaction in Cardiac Surgery
- First Posted Date
- 2012-01-26
- Last Posted Date
- 2012-01-26
- Lead Sponsor
- Konkuk University Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT01518569
- Locations
- 🇰🇷
Konkuk University Medical Center, Seoul, Korea, Republic of
Ulinastatin in Inhalation Lung Injury
- First Posted Date
- 2011-02-01
- Last Posted Date
- 2011-02-01
- Lead Sponsor
- Chinese PLA General Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT01287806
- Locations
- 🇨🇳
304 hospital of PLA, Beijin, Beijin, China
Ulinastatin in Severe Acute Pancreatitis
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Techpool Bio-Pharma Co., Ltd.
- Target Recruit Count
- 252
- Registration Number
- NCT01132521
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
🇨🇳Wuhan Union Hospital of China, Wuhan, Hubei, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
Hemostatic Effects of Ulinastatin and Tranexamic Acid in Cardiac Surgery
Not Applicable
Completed
- Conditions
- Hemostasis
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2019-02-05
- Lead Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Target Recruit Count
- 426
- Registration Number
- NCT01060189
- Locations
- 🇨🇳
Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC, Beijing, Beijing, China
Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2011-05-27
- Lead Sponsor
- Yonsei University
- Registration Number
- NCT00944385
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath